본문 바로가기

Single monosomy as a relatively better survival factor in acute myeloid leukemia patients with monosomal karyotype

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q2Scopus Q2
저널
BLOOD CANCER JOURNAL5 · 2015
피인용
Web of Science 15
JCR IF
JCR 2014 3.467
ISSN
2044-5385

저자

  1. Jang, J. E.제1저자연세대학교, Coll Med, Severance Hosp, KO
  2. Min, Y. H.연세대학교, Coll Med, Severance Hosp, KO
  3. Yoon, J.가톨릭대학교, Seoul St Marys Hosp, Canc Res Inst, KO
  4. Kim, I.서울대학교, Coll Med, Dept Internal Med, KO
  5. Lee, J-H울산대학교, Dept Hematol, Asan Med Ctr, KO
  6. Jung, C. W.성균관대학교, Sch Med, Samsung Med Ctr, KO
  7. 신호진부산대학교, 의과대학, 의학과, 내과학교실, KO
  8. Lee, W. S.인제대학교, Dept Hematooncol, Dept Internal Med, KO
  9. Lee, J. H.가천대학교, Gil Med Ctr, Dept Internal Med, KO
  10. Hong, D-S순천향대학교, Div Hematol & Oncol, Dept Internal Med, KO
  11. Kim, H-J가톨릭대학교, Dept Hematol & Oncol, Hwasun Hosp, KO
  12. Kim, H-JCatholic Inst Visual Sci, 의학과
  13. Park, S.서울대학교, Coll Med, Dept Internal Med, KO
  14. Lee, K-H울산대학교, Dept Hematol, Asan Med Ctr, KO
  15. Jang, J. H.성균관대학교, Sch Med, Samsung Med Ctr, KO
  16. 정주섭부산대학교, 의과대학, 의과학과, KO
  17. Lee, S. M.인제대학교, Dept Hematooncol, Dept Internal Med, KO
  18. Park, J.가천대학교, Gil Med Ctr, Dept Internal Med, KO
  19. Park, S. K.순천향대학교, Div Hematol & Oncol, Dept Internal Med, KO
  20. Ahn, J-S전남대학교, Dept Hematol & Oncol, Hwasun Hosp, KO
  21. Min, W-S교신저자가톨릭대학교, Seoul St Marys Hosp, Canc Res Inst, KO
  22. Cheong, J-W연세대학교, Coll Med, Severance Hosp, KO

초록

Monosomal karyotype (MK) defined by either >= 2 autosomal monosomies or single monosomy with at least one additional structural chromosomal abnormality is associated with a dismal prognosis in patients with acute myeloid leukemia (AML). It was detected in 174 of 3041 AML patients in South Korean Registry. A total of 119 patients who had received induction therapy were finally analyzed to evaluate the predictive factors for a positive prognosis. On multivariate analysis, single monosomy, the absence of abn(17p), >= 10% of cells with normal metaphase and the achievement of a complete remission (CR) after induction therapy were significant factors for more favorable outcomes. Especially, single monosomy remained as a significantly independent prognostic factor for superior survival in both patients who received allogeneic hematopoietic stem cell transplantation (allo-HSCT) in CR and who did not. Allo-HSCT in CR improved overall survival significantly only in patients with a single monosomy. Our results suggest that MK-AML may be biologically different according to the karyotypic subtype and that allo-HSCT in CR should be strongly recommended to patients with a single monosomy. For other patients, more prudent treatment strategies should be examined. Furthermore, the biological mechanism by which a single monosomy influences survival should be investigated.

키워드

STEM-CELL TRANSPLANTATIONCOMPLEX ABERRANT KARYOTYPEPROGNOSTIC IMPACTPOOR-PROGNOSISMYELODYSPLASTIC SYNDROMEPOSTREMISSION THERAPYTP53 MUTATIONDELETIONADULTSUBGROUP

식별자

WoS UID
000368920300008